Search research articles
Contact Us
Filters
Showing results (111-120 of 204) with videos related to
Page
of 21
Sort By:
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trial
Emily C L Wong, Nazmus Khan, Parambir S Dulai, et al.
The American Journal of Gastroenterology
|
February 2, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis with Severe Endoscopic Disease
Emily C L Wong, Vipul Jairath, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
January 8, 2019
Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease
Neeraj Narula, Maria Ines Pinto-Sanchez, Natalia Causada Calo, et al.
Scandinavian Journal of Gastroenterology
|
June 24, 2020
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
Neil K Sengupta, Ahmad Azizov, Smita Halder, et al.
Alimentary Pharmacology & Therapeutics
|
July 28, 2025
Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
Mohammad Shehab, Fatema Alrashed, Abdulrahman Alrashidi, et al.
Journal of Crohn'S & Colitis
|
November 12, 2024
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
The American Journal of Gastroenterology
|
February 10, 2016
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids
Neeraj Narula, John K Marshall, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 25, 2024
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
Mohammad Shehab, Fatema Alrashed, Abdulwahab Alsayegh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 23, 2021
Reply
Emily C L Wong, Jean-Frederic Colombel, Robert Riddell, et al.
Journal of Crohn'S & Colitis
|
November 27, 2020
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease
Emily C L Wong, Elisa Buffone, So Jeong Lee, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 204) with videos related to
Sort By:
Page
of 21
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trial
Emily C L Wong, Nazmus Khan, Parambir S Dulai, et al.
The American Journal of Gastroenterology
|
February 2, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis with Severe Endoscopic Disease
Emily C L Wong, Vipul Jairath, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
January 8, 2019
Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease
Neeraj Narula, Maria Ines Pinto-Sanchez, Natalia Causada Calo, et al.
Scandinavian Journal of Gastroenterology
|
June 24, 2020
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
Neil K Sengupta, Ahmad Azizov, Smita Halder, et al.
Alimentary Pharmacology & Therapeutics
|
July 28, 2025
Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
Mohammad Shehab, Fatema Alrashed, Abdulrahman Alrashidi, et al.
Journal of Crohn'S & Colitis
|
November 12, 2024
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
The American Journal of Gastroenterology
|
February 10, 2016
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids
Neeraj Narula, John K Marshall, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 25, 2024
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
Mohammad Shehab, Fatema Alrashed, Abdulwahab Alsayegh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 23, 2021
Reply
Emily C L Wong, Jean-Frederic Colombel, Robert Riddell, et al.
Journal of Crohn'S & Colitis
|
November 27, 2020
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease
Emily C L Wong, Elisa Buffone, So Jeong Lee, et al.
Page
of 21